Literature DB >> 12451219

The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians.

O O Favorova1, T V Andreewski, A N Boiko, M A Sudomoina, A D Alekseenkov, O G Kulakova, A V Slanova, E I Gusev.   

Abstract

The authors studied the possible association between the presence of a 32-base pair deletion allele in CC chemokine receptor 5 gene [3p21] (CCR5 Delta 32 allele) and the occurrence of MS. The presence of CCR5 Delta 32 homozygotes among patients with MS indicates that the absence of CCR5 did not protect against MS. Moreover, the CCR5 Delta 32 mutation was associated with MS in HLA-DR4-positive Russians (p(corr) < 0.001, odds ratio [OR] = 25.0). The (CCR5 Delta 32,DR4)-positive phenotype was negatively associated with early MS onset (at ages < or = 18 years) (p = 0.0115, OR = 0.1).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12451219     DOI: 10.1212/01.wnl.0000035626.92372.0a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans.

Authors:  Alexander V Favorov; Timophey V Andreewski; Marina A Sudomoina; Olga O Favorova; Giovanni Parmigiani; Michael F Ochs
Journal:  Genetics       Date:  2005-08-22       Impact factor: 4.562

Review 2.  Is the CCR5 Δ 32 mutation associated with immune system-related diseases?

Authors:  Khodayar Ghorban; Maryam Dadmanesh; Gholamhossein Hassanshahi; Mohammad Momeni; Mohammad Zare-Bidaki; Mohammad Kazemi Arababadi; Derek Kennedy
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

Review 3.  A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.

Authors:  V V Bashinskaya; O G Kulakova; A N Boyko; A V Favorov; O O Favorova
Journal:  Hum Genet       Date:  2015-09-25       Impact factor: 4.132

4.  CCR5-delta 32 allele is associated with the risk of developing multiple sclerosis in the Iranian population.

Authors:  Majid Shahbazi; Hamid Ebadi; Davood Fathi; Danial Roshandel; Mana Mahamadhoseeni; Azam Rashidbaghan; Narges Mahammadi; Mahammad Reza Mahammadi; Mahdi Zamani
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

5.  Three allele combinations associated with multiple sclerosis.

Authors:  Olga O Favorova; Alexander V Favorov; Alexey N Boiko; Timofey V Andreewski; Marina A Sudomoina; Alexey D Alekseenkov; Olga G Kulakova; Eugenyi I Gusev; Giovanni Parmigiani; Michael F Ochs
Journal:  BMC Med Genet       Date:  2006-07-26       Impact factor: 2.103

6.  CCR2-64I and CCR5Delta32 Polymorphisms in Korean Patients with Myasthenia Gravis.

Authors:  Hyun Sook Kim; Dae-Seong Kim; Eun Young Lee; Il-Nam Sunwoo; Young-Chul Choi
Journal:  J Clin Neurol       Date:  2007-09-20       Impact factor: 3.077

7.  A Polygenic Approach to the Study 
of Polygenic Diseases.

Authors:  D Lvovs; O O Favorova; A V Favorov
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.